Video from AACC: PerkinElmer on diagnostics, acquisitions

Leo O'Connor
Aug 1, 2022
2022 08 02 13 04 9265 Greg Stock Perkinelmer 400

Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.

Click on the video below for the interview.

Greg Stock, general manager of PerkinElmer's Euroimmun business.

Latest in Mergers & Acquisitions
Business Handshake Man Social
Bruker to acquire NanoString for $392.6M
April 18, 2024
Heart Artificial Intelligence Ai Social
Johnson & Johnson to acquire Shockwave Medical
April 8, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Business Graph Money Stocks Social
AbbVie to buy Landos Biopharma for up to $212M
March 25, 2024
Related Stories
Gene Therapy Dna Scientist Social
Immunoassays
PerkinElmer launches adeno-associated virus vector detection kits for research
Baby Bottle Social
Regulatory Approval
PerkinElmer nabs first FDA authorization for assay to screen for spinal muscular atrophy in newborns
Business Economics Pie Chart Social
Financial Results
PerkinElmer Q3 revenues down 14% on diagnostics decline
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Mergers & Acquisitions
Bruker to acquire NanoString for $392.6M
By LabPulse.com staff writers
NanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.
April 18, 2024
Business Handshake Man Social
Johnson & Johnson to acquire Shockwave Medical
By LabPulse.com staff writers
Johnson & Johnson will acquire Shockwave Medical, expanding Johnson & Johnson MedTech's position in the growing medtech market for cardiovascular intervention.
April 8, 2024
Heart Artificial Intelligence Ai Social
Labcorp acquires BioReference Health assets
By LabPulse.com staff writers
Labcorp and Opko Health subsidiary BioReference Health have announced that they have made an agreement for Labcorp to acquire certain of BioReference Health’s assets.
March 28, 2024
Hands Shaking2 Social
AbbVie to buy Landos Biopharma for up to $212M
By LabPulse.com staff writers
AbbVie has announced that it will buy drug developer Landos Biopharma in a deal worth up to $212 million. The deal will expand Abbvie’s portfolio, especially in the arena of immune system-related illnesses.
March 25, 2024
Business Graph Money Stocks Social
Ginkgo Bioworks acquires 3 companies
By LabPulse.com staff writers
Ginkgo Bioworks has acquired three startups: gene-editing diagnostics developer Proof Diagnostics, artificial intelligence (AI)-driven drug discovery company Reverie Labs, and AI platform developer Patch Biosciences.
February 29, 2024
Business Economics Pie Chart2 Social
Bruker enters agreement to acquire ELITechGroup
By LabPulse.com staff writers
Life sciences and diagnostics firm Bruker has entered into a definitive share purchase agreement with Paris-based private equity firm PAI Partners to acquire molecular diagnostics firm ELITechGroup, excluding its ELITech clinical chemistry business.
February 28, 2024
Business Handshake Intelligence Social
German regulatory agency opens review of Thermo Fisher, Olink deal
By LabPulse.com staff writers
Germany’s antitrust regulatory agency, the Bundeskartellamt, has moved into a phase II review of Thermo Fisher’s acquisition of Swedish proteomics firm Olink.
February 22, 2024
Regulation Wheel Social
Bruker eyes Chemspeed to accelerate entry into lab automation market
By LabPulse.com staff writers
Basel, Switzerland-based Bruker announced that it plans to acquire Chemspeed to accelerate Bruker’s entry into the lab automation, digitalization, and scientific software solutions market.
February 2, 2024
Digital Science Lab Social
Invitae sells reproductive health assets to Natera
By LabPulse.com staff writers
Invitae on Monday has completed the sale of some of its reproductive health assets, including carrier screening and noninvasive prenatal screening, to Natera.
January 22, 2024
Business Men Handshake Social
Steward offloads outreach laboratory services business
By LabPulse.com staff writers
Quest Diagnostics has acquired select assets of outreach laboratory services in Pennsylvania and Ohio from Steward Health Care System, a large, private, and fully-integrated for-profit system based in Dallas.
January 9, 2024
Quest Diagnostics Newsroom Media Gallery Photo Social
Tome Biosciences acquires Replace Therapeutics in $65M deal
By LabPulse.com staff writers
Less than a month after Tome Biosciences emerged with $213 million in funding, the gene editing company will acquire Replace Therapeutics for $65 million in upfront and near-term milestones, with a total deal value of up to $185 million.
January 5, 2024
Dna Sequence Social
Roche signs $350M deal to buy POC technology from LumiraDx
By LabPulse.com staff writers
Roche has entered into a definitive agreement to purchase point-of care (POC) technologies from LumiraDx for $295 million, with an additional payment of up to $55 million to fund the POC diagnostics platform business until the transaction closes.
January 3, 2024
Hands Shaking Deal Social
Page 1 of 11
Next Page